Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.66 |
| ▸ | HDAC6 | Q9UBN7 | 14/20 | 0.66 |
| ▸ | HDAC4 | P56524 | 13/20 | 0.66 |
| ▸ | HDAC1 | Q13547 | 13/20 | 0.66 |
| ▸ | HDAC7 | Q8WUI4 | 13/20 | 0.66 |
| ▸ | HDAC11 | Q96DB2 | 13/20 | 0.66 |
| ▸ | HDAC8 | Q9BY41 | 13/20 | 0.66 |
| ▸ | HDAC9 | Q9UKV0 | 13/20 | 0.66 |
| ▸ | HDAC5 | Q9UQL6 | 13/20 | 0.66 |
| ▸ | HDAC3 | O15379 | 12/20 | 0.66 |
| ▸ | HDAC2 | Q92769 | 12/20 | 0.66 |
| ▸ | HDAC10 | Q969S8 | 12/20 | 0.66 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.66 |
| ▸ | NCOR1 | O75376 | 2/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.66 |
| ▸ | BRD4 | O60885 | 1/20 | 0.66 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.66 |
| ▸ | EGFR | P00533 | 1/20 | 0.66 |
| ▸ | NR0B1 | P51843 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13973103 | 0.94 | HDAC6 (0.69) | LTA4HHDAC6HDAC4HDAC1HDAC7 | |
| SCHEMBL4837664 | 0.93 | HDAC6 (0.72) | LTA4HHDAC6HDAC4HDAC1HDAC7 | |
| Hydrochloric Acid SCHEMBL28515049 | 0.93 | HDAC6 (0.67) | LTA4HHDAC6HDAC4HDAC1HDAC7 | |
| SCHEMBL28608420 | 0.93 | HDAC6 (0.72) | LTA4HHDAC6HDAC4HDAC1HDAC7 | |
| SCHEMBL31203555 | 0.93 | HDAC6 (0.72) | LTA4HHDAC6HDAC4HDAC1HDAC7 | |
| SCHEMBL14135053 | 0.93 | HDAC6 (0.72) | LTA4HHDAC6HDAC4HDAC1HDAC7 | |
| Hydrochloric Acid SCHEMBL8750137 | 0.91 | HDAC6 (0.70) | LTA4HHDAC6HDAC4HDAC1HDAC7 | |
| Hydrochloric Acid SCHEMBL827279 | 0.91 | HDAC6 (0.70) | LTA4HHDAC6HDAC4HDAC1HDAC7 | |
| Trifluoroacetic Acid SCHEMBL321237 | 0.90 | HDAC4 (0.66) | LTA4HHDAC6HDAC4HDAC1HDAC7 | |
| SCHEMBL4400398 | 0.90 | L3MBTL1 (0.71) | LTA4HHDAC6HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107814796-B | Environment-sensitive dye based on benzofurazan and preparation method and application thereof | 湖南大学 | 2020-10-02 | — | — | CN | disclosed |
| US-20120009151-A1 | Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof | PROGENICS PHARMACEUTICALS, INC. (US) | 2012-01-12 | — | — | US | disclosed |
| US-8093227-B2 | Monosaccharide compounds and methods therefor | ALCHEMIA PTY LTD (AU) | 2012-01-10 | — | — | US | disclosed |
| US-8093227-B2 | Monosaccharide compounds and methods therefor | ALCHEMIA PTY LTD (AU) | 2012-01-10 | — | — | US | disclosed |
| US-20100184607-A1 | MONOSACCHARIDE COMPOUNDS AND METHODS THEREFOR | ALCHEMIA PTY LTD. (AU) | 2010-07-22 | — | — | US | disclosed |
| US-20100184607-A1 | MONOSACCHARIDE COMPOUNDS AND METHODS THEREFOR | ALCHEMIA PTY LTD. (AU) | 2010-07-22 | — | — | US | disclosed |
| US-7417129-B2 | Combinatorial libraries of monosaccharides | ALCHEMIA PTY LTD (AU) | 2008-08-26 | — | — | US | disclosed |
| US-7417129-B2 | Combinatorial libraries of monosaccharides | ALCHEMIA PTY LTD (AU) | 2008-08-26 | — | — | US | disclosed |
| EP-0463993-B1 | Process for the preparation of aminoanthraquinone derivatives | CIBA SC HOLDING AG (CH) | 2002-05-02 | — | — | EP | disclosed |
| EP-0596802-B1 | Erythromycin derivatives, their process of preparation and their application as medicaments | ROUSSEL UCLAF (FR) | 1996-03-20 | — | — | EP | disclosed |
| EP-0596802-A1 | Erythromycin derivatives, their process of preparation and their application as medicaments | ROUSSEL UCLAF (FR) | 1994-05-11 | — | — | EP | disclosed |
| US-5196553-A | From bromaminic acid and a benzenesulfonamide or an amide, copper/I/ catalyst formed by in situ reduction of a copper/II/ salt, less copper required | CIBA-GEIGY CORPORATION (US) | 1993-03-23 | — | — | US | disclosed |
| EP-0463993-A1 | Process for the preparation of aminoanthraquinone derivatives | CIBA-GEIGY AG (CH) | 1992-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184607-A1 | MONOSACCHARIDE COMPOUNDS AND METHODS THEREFOR | SLC5A1, UGGT1, MRPL21 | LTA4H 1970/4885HDAC6 764/4885HDAC4 1649/4885 |
| US-20120009151-A1 | Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof | HAVCR2, ZC3HAV1, MAVS | LTA4H 3370/4885HDAC6 468/4885HDAC4 660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.